Clinical Trials Sponsored by Hoxworth+Blood+Center

Total 1206 results

University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns

Bronchopulmonary Dysplasia

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Withdrawn

Determining in Vitro Properties of Epithelial Cells From Individuals With Genetic Variants Associated With Idiopathic Pulmonary Fibrosis

Healthy | Idiopathic Pulmonary Fibrosis

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants

Lung Diseases | Bronchopulmonary Dysplasia

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Improving Prevention of Heart Disease in Latinos (LUCHAR)

Heart Diseases | Cardiovascular Diseases | Hypertension | Diabetes Mellitus

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Leukemia

United States
University of Colorado, Denver
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians

Heart Diseases | Cardiovascular Diseases
The Canadian Blood and Marrow Transplant Group
National Cancer Institute (NCI)

Completed

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Graft Versus Host Disease | Secondary Myelofibrosis

Australia, Canada, United States, New Zealand, Saudi Arabia
Institute of Oncology Ljubljana
University Medical Centre Ljubljana; University of Ljubljana; Blood Transfusion...

Not yet recruiting

Treatment of Post-radiation Xerostomia With Allogeneic Mesenchymal Stromal Stem Cells

Xerostomia Following Radiotherapy

Slovenia
Kaiser Permanente
National Heart, Lung, and Blood Institute (NHLBI); Beth Israel Deaconess Medical... and other collaborators

Recruiting

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial (NACAM)

Myocardial Injury | Acute Kidney Injury | Ischemia Reperfusion Injury

United States
National Heart, Lung, and Blood Institute (NHLBI)
Medstar Washington Hospital Center

Recruiting

Technical Development of Cardiovascular Magnetic Resonance Imaging

Cardiovascular Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)
Medstar Washington Hospital Center

Withdrawn

Use of Cardiac-MRI to Predict Results for People With Severe Aortic Stenosis

Aortic Valve Stenosis
National Heart, Lung, and Blood Institute (NHLBI)
University of California, San Francisco; RTI International; Versiti; Blood Systems... and other collaborators

Completed

Hemoglobin and Iron Recovery Study (HEIRS)

Recovery of Hemoglobin and Iron Stores After Blood Donation

United States
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

Heart Failure

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure

Severe Aplastic Anemia | Single Lineage Cytopenias, T-LGL | Hypoplastic MDS

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Exploring Near Infrared Spectroscopy (NIRS) Technologies for Assessment of Muscle Physiology, Tissue Oxygenation, and Blood Flow in Patients With Sickle Cell Disease (SCD)

SCD

United States
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

NHLBI-Emory Advanced Cardiac CT Reconstruction

Structural Heart Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia

Sickle Cell Anemia | Beta Thalassemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes

Severe Aplastic Anemia | Telomere Biology Disorders | Inherited Bone Marrow Failure Syndromes

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Severe Aplastic Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

CHIP/CCUS Natural History Protocol

Clonal Cytopenia of Undetermined Significance | Clonal Hematopoiesis of Indeterminate Potential

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Vascular Disease Discovery Protocol

Genetic Predisposition | Vascular Dysfunction | Genetic Mutations

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

CAD

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

Severe Aplastic Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Human Biospecimen Procurement Protocol: Biorepository to Support Translational Research to Identify Disease Mechanism(s)

Cardiovascular Disease | Undiagnosed Diseases

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Genome Transplant Dynamics

Thoracic Organ Transplantation

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

Healthy Subjects

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Heart Health Study in Washington D.C. to Develop a Community-Based Behavioral Weight Loss Intervention

Obesity | Cardiovascular Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Evaluating New Radiation Techniques for Cardiovascular Imaging

Coronary Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

MDS (Myelodysplastic Syndrome) | Severe Aplastic Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Natural History of Bronchiectasis

Bronchiectasis | Common Variable Immunodeficiency | Cystic Fibrosis | Autoimmune Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers

Healthy Volunteers

United States
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease

Sickle Cell Disease | Sickle Cell Trait

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cardiac Function in Patients With Hereditary Hemochromatosis

Hereditary Hemochromatosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

Inflammation | Cardiovascular Disease | Psoriasis | Metabolic Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Fasting and Refeeding on T-cell Fate

Inflammation | Asthma

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Cardiovascular Evaluation of Patients With High Cholesterol and Normal Volunteers

Homozygous Familial Hypercholesterolemic

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

High Image Matrix CT Reconstruction

Healthy Subjects | Pulmonary-Related Conditions | Cardiac-Related Conditions

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Genes Involved in Lipid Disorders

Lipid Disorders

United States
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

Sickle Cell Disease | Hemolytic Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Characterization of the Pathogenesis of Primary and Secondary Lymphatic Disorders

Lymphedema | Lymphangiomatosis | Lymphangiectasia | Pulmonary Lymphangiectasia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

WS-SAVE Study (Williams Syndrome Skin and Vessel Elasticity Study)

Hypertension | Cardiovascular Disease | Williams Syndrome | Multisystem Developmental Disorder | Elastin Gene Deletion

United States
National Institutes of Health Clinical Center (CC)
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of a Stress Reduction Intervention in Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

Stress, Psychological | Caregivers

United States
Cedars-Sinai Medical Center
National Heart, Lung, and Blood Institute (NHLBI); American Heart Association

Completed

3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery

Carotid Artery Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Anti-Inflammatory Effects of Time-Restricted Feeding

Psoriasis | Systemic Inflammation

United States
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease

Sickle Cell Disease

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Hereditary Parkinson s Disease Natural History Protocol

Parkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1

United States
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study

Functional Mitral Regurgitation

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy

Severe Aplastic Anemia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement

Aortic Stenosis

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy

Severe Aplastic Anemia

United States

Clinical Trials Sponsored by Hoxworth+Blood+Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations